WHO identifies Ebola treatments, vaccines be tested in trials amid outbreak
Summary
The World Health Organization has prioritized three experimental treatments and vaccines for the Bundibugyo strain of Ebola to be tested in clinical trials amid ongoing outbreaks in the Democratic Republic of the Congo and Uganda.
Key Points
- WHO recommends prioritizing three experimental treatments for the Bundibugyo strain of Ebola: MBP134, maftivimab, and remdesivir.
- Clinical trials are advised to evaluate the efficacy of these drugs and candidate vaccines.
- The outbreak is ongoing in the Democratic Republic of the Congo with cases also in Uganda.
- WHO is collaborating with local authorities and partners like Africa CDC to conduct ethically sound clinical trials.
